2023-03-30T16:58:22+08:00 weekly 1.0 https://gr.prisysbiotech.com/ 2024-11-12T04:56:29+08:00 weekly 0.9 https://gr.prisysbiotech.com/animal-welfare 2024-11-12T04:56:25+08:00 weekly 0.9 https://gr.prisysbiotech.com/translational-research-center 2023-02-27T15:56:40+08:00 weekly 0.9 https://gr.prisysbiotech.com/co-develop 2024-11-12T05:19:08+08:00 weekly 0.9 https://gr.prisysbiotech.com/hematological-disease-research 2024-11-12T05:19:20+08:00 weekly 0.9 https://gr.prisysbiotech.com/respiratory-disease-research 2024-11-12T05:19:20+08:00 weekly 0.9 https://gr.prisysbiotech.com/metabolic-syndromes-research 2024-11-12T05:19:13+08:00 weekly 0.9 https://gr.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-12T05:19:06+08:00 weekly 0.9 https://gr.prisysbiotech.com/ophthalmic-disease-research 2024-11-12T05:19:05+08:00 weekly 0.9 https://gr.prisysbiotech.com/inflammation-immunology-disorders 2024-11-12T05:19:03+08:00 weekly 0.9 https://gr.prisysbiotech.com/download 2024-11-12T05:19:17+08:00 weekly 0.9 https://gr.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://gr.prisysbiotech.com/fibrosis 2024-11-12T04:56:26+08:00 weekly 0.9 https://gr.prisysbiotech.com/about-us 2024-11-12T04:56:26+08:00 weekly 0.9 https://gr.prisysbiotech.com/contact-us 2023-03-31T10:50:46+08:00 weekly 0.9 https://gr.prisysbiotech.com/newslist-1 2024-11-12T04:56:28+08:00 weekly 0.9 https://gr.prisysbiotech.com/products 2023-03-31T10:32:21+08:00 weekly 0.9 https://gr.prisysbiotech.com/pk-pd-adme/ 2023-03-31T10:32:21+08:00 weekly 0.9 https://gr.prisysbiotech.com/translation-research/ 2023-03-31T10:32:21+08:00 weekly 0.9 https://gr.prisysbiotech.com/biosafety-research/ 2023-03-31T10:32:21+08:00 weekly 0.9 https://gr.prisysbiotech.com/safety-evaluation/ 2023-03-31T10:32:22+08:00 weekly 1.0 https://gr.prisysbiotech.com/nhp-pharmacology/ 2024-04-10T11:05:06+08:00 weekly 0.9 https://gr.prisysbiotech.com/clearpoint/ 2023-03-31T10:51:09+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2023-03-31T10:51:08+08:00 weekly 0.8 https://gr.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2024-11-12T04:56:24+08:00 weekly 0.8 https://gr.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-12T05:19:17+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2024-11-12T05:19:03+08:00 weekly 0.8 https://gr.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2023-03-31T10:51:09+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-12T04:56:25+08:00 weekly 0.8 https://gr.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2023-03-31T10:51:14+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2023-03-31T10:51:12+08:00 weekly 0.8 https://gr.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-12T04:56:23+08:00 weekly 0.8 https://gr.prisysbiotech.com/translation-research/nhpresources.html 2023-03-31T10:51:13+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-03-31T10:51:11+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-11-12T04:56:30+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-03-31T10:52:59+08:00 weekly 0.8 https://gr.prisysbiotech.com/safety-evaluation/toxicology.html 2023-03-31T10:51:14+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-12T05:19:03+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2023-03-31T10:51:20+08:00 weekly 0.8 https://gr.prisysbiotech.com/translation-research/translational-studies.html 2023-03-31T10:51:21+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-12T05:19:03+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-12T04:56:43+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-12T05:19:07+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-12T04:56:24+08:00 weekly 0.8 https://gr.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-03-31T10:51:15+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2023-03-31T10:51:13+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-12T05:19:08+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2023-03-31T10:51:11+08:00 weekly 0.8 https://gr.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-12T04:56:28+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-31T10:51:13+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2024-11-12T05:19:04+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-12T04:56:28+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2024-11-12T05:19:16+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2023-03-31T10:51:16+08:00 weekly 0.8 https://gr.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-12T04:56:25+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2024-11-12T05:19:09+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-12T05:19:11+08:00 weekly 0.8 https://gr.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2024-11-12T04:56:44+08:00 weekly 0.8 https://gr.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-12T05:19:07+08:00 weekly 0.8 https://gr.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-12T05:19:11+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-12T05:19:19+08:00 weekly 0.8 https://gr.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-26T14:07:50+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-09-26T14:07:54+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-26T14:07:56+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-11-12T04:56:31+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-26T14:07:57+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-26T14:08:00+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-26T14:08:06+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-12-08T05:18:17+08:00 weekly 0.8 https://gr.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-08T07:40:37+08:00 weekly 0.8 https://gr.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-01T23:12:25+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-04-01T23:12:28+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-21T00:53:29+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-21T00:53:37+08:00 weekly 0.8 https://gr.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-22T16:23:17+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-14T18:31:21+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T17:04:14+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T08:34:04+08:00 weekly 0.8 https://gr.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-01T22:24:39+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T18:28:42+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T22:39:33+08:00 weekly 0.8 https://gr.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-03-31T10:51:04+08:00 weekly 0.9 https://gr.prisysbiotech.com/newslist-713600-1 2023-03-31T10:51:05+08:00 weekly 0.9 https://gr.prisysbiotech.com/newslist-713601-1 2024-07-29T16:28:52+08:00 weekly 0.9 https://gr.prisysbiotech.com/newslist-818679-1 2023-03-31T10:51:06+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/meetprisys-sot2023-66085899.html 2023-03-31T10:51:07+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66085900.html 2023-03-31T10:51:08+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-sot2023-66085901.html 2023-03-31T10:51:08+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66085902.html 2023-03-31T10:51:06+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66085903.html 2023-03-31T10:51:09+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66085904.html 2023-03-31T10:51:10+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66085905.html 2023-03-31T10:51:09+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66085906.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66085909.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/gene-therapy-nhp-model-66086396.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/gene-therapy-toxicology-66267169.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/world-parkinsons-disease-day-67237777.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67237778.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67237779.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67237780.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67237781.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67237782.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67237783.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67237784.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68102460.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68102464.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68102465.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68105391.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68307960.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-68996301.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-68997173.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-68997901.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-68998002.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-68998756.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69000296.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309350.html 2023-07-16T21:49:54+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309370.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309378.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309407.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69653810.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69653812.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70941343.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70941344.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70941345.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70941346.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/0-70941348.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70941349.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321023.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321024.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321025.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321027.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321028.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72673466.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73001100.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73525319.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73525320.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74241728.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654536.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74782673.html 2024-11-12T04:56:21+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75160409.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75160410.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76173243.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77051945.html 2024-11-12T04:56:30+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77693847.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77693853.html 2024-11-12T04:56:23+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79185916.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79185917.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-asthma-model-79185919.html 2024-11-12T05:18:58+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79185923.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79185924.html 2024-11-12T05:18:59+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410632.html 2024-11-12T04:56:18+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410633.html 2024-11-12T04:56:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410634.html 2024-11-12T04:56:23+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pk-strategies-of-pdc-79527251.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79527253.html 2024-11-12T04:56:18+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79527254.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79527257.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79527258.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79527259.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79527260.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79527261.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79527262.html 2024-11-12T05:19:05+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79527263.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79527264.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79527265.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79527266.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79527267.html 2024-11-12T04:56:23+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79527268.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79527269.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79527270.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79527271.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79527272.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79527273.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79527274.html 2024-11-12T04:56:20+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79527275.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79527276.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79527277.html 2024-11-12T04:56:17+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79527278.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79527279.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527282.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79527283.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79527284.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79527285.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79527286.html 2024-11-12T04:56:24+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79527287.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79527288.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527289.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79527290.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79527291.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79527293.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79527294.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79527295.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79527296.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79527297.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/significance-principles-and-requirements-of-79527298.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/mrna-based-therapies-present-79527299.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79527300.html 2024-11-12T04:56:17+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/mrna-based-therapies-past-79527944.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79527945.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79527946.html 2024-08-07T08:44:33+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656479.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120471.html 2024-11-12T04:56:27+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/convection-enhanced-delivery-81120472.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120473.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120474.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/china-experimental-monkey-industry-81120475.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/human-disease-animal-models-81120476.html 2024-11-12T04:56:28+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81120477.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/animal-models-of-human-diseases-81120478.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120480.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120481.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120482.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120498.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/compartment-pk-model-81120862.html 2024-11-12T05:19:10+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82342035.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82806840.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82806841.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82806842.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82806843.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82806844.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82806845.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82806846.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82806849.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82806851.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83036100.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83036361.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83039229.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83997129.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83997130.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83997131.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83997135.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83997136.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83997156.html 2025-01-19T02:07:16+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83997158.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83997205.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83997889.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243977646302208.html 2025-02-27T01:25:50+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17244015886345216.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295480329905152.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295480412890112.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295480437400576.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295480463057920.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/membranous-nephropathy-model-17295480464286720.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/animal-models-for-womens-health-17295480478622720.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295480485012480.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295480516584448.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295480625374208.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295480700593152.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295480707343360.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295480713585664.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295480775681024.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295480780841984.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295480979596288.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295512240464896.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295512298234880.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17299247547917312.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374222352884736.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374222353163264.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374222353835008.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374222369039360.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374222370563072.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374222453187584.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374222468113408.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374222477206528.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374222590419968.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374222604755968.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374222770332672.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374222887986176.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17451293320438784.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17451293404685312.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17451293436240896.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17451293439026176.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17451293496583168.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17451293570212864.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17451293608993792.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17451293630604288.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17451293670794240.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17451294173242368.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17451294196704256.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/key-considerations-for-dosing-volume-17451332253934592.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17497463971652608.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-copd-model-17497464046937088.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17497464052573184.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17497464059995136.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17497464109327360.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17497464156791808.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530189955359744.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/brain-targeted-drug-delivery-17530189962667008.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530190060610560.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530190250664960.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530190269522944.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530190279058432.html 2025-09-14T19:09:48+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/the-importance-of-administration-volume-17530212297401344.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538597769733120.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17554484366025728.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625519934022656.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625520121766912.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625520142164992.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625520147620864.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625520166839296.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625520219546624.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-renal-biopsy-17625520311706624.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625520355238912.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625520371360768.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625520392201216.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625520418219008.html 2025-12-25T18:28:35+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674565191754752.html 2025-12-25T18:29:02+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674565329396736.html 2025-12-25T18:28:47+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674565392344064.html 2025-12-25T18:28:43+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674565430748160.html 2025-12-25T18:28:46+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674565461025792.html 2025-12-25T18:28:53+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674565524530176.html 2025-12-25T18:28:55+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674566069363712.html 2025-12-25T18:40:19+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674576286573568.html 2025-12-25T18:40:32+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674576461915136.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724334855349248.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724334860985344.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724334898357248.html 2026-04-08T04:39:22+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724335932679168.html 2026-01-29T22:39:37+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724348824069120.html 2026-01-29T22:39:30+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724348875613184.html 2026-01-29T22:39:47+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724348929729536.html 2026-01-29T22:39:59+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724348967019520.html 2026-01-29T22:39:57+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724349168952320.html 2026-01-29T22:39:40+08:00 weekly 0.8 https://gr.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724349321929728.html